We are live on ! Find out more
GC

Greenlight Capital Portfolio holdings

AUM $2.05B Turnover 28.26%
1-Year Est. Return 78.75%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+78.75%
3 Year Est. Return
+169.15%
5 Year Est. Return
+457.09%
10 Year Est. Return
+683.15%
AUM
$1.76B
AUM Growth
-$372M
Cap. Flow
-$265M
Cap. Flow %
-15.02%
Top 10 Hldgs %
79.64%
Holding
42
New
1
Increased
21
Reduced
7
Closed
3
Avg Time Held
1.9 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
1.9 years

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$36.4M
2
DHT icon
DHT Holdings
DHT
+$18.9M
3
KD icon
Kyndryl
KD
+$16.9M
4
HRI icon
Herc Holdings
HRI
+$11.8M
5
LIVN icon
LivaNova
LIVN
+$8.35M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.88%
2 Energy 23.75%
3 Financials 12.49%
4 Healthcare 7.84%
5 Technology 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
REZI icon
26
Resideo Technologies
REZI
$2.52B
$5.12M 0.29%
324,010
-165,289
-34% -$2.78M
2020 Q2
13 quarters
SHC icon
27
Sotera Health
SHC
$5.16B
$5.05M 0.29%
336,970
+331,520
+6,083% +$5.59M
2023 Q2
1 quarter
OIH icon
28
VanEck Oil Services ETF
OIH
$1.79B
$2.4M 0.14%
6,960
– –
2023 Q1
2 quarters
AAP icon
29
Advance Auto Parts
AAP
$2.65B
$2.1M 0.12%
37,570
– –
2023 Q2
1 quarter
GANX icon
30
Gain Therapeutics
GANX
$58M
$1.93M 0.11%
588,410
+41,850
+8% +$159K
2021 Q1
10 quarters
COYA icon
31
Coya Therapeutics
COYA
$102M
$1.8M 0.1%
468,067
+75,420
+19% +$300K
2022 Q4
3 quarters
FCG icon
32
First Trust Natural Gas ETF
FCG
$657M
$1.52M 0.09%
58,540
– –
2023 Q1
2 quarters
PDBC icon
33
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.96B
$1.45M 0.08%
96,990
– –
2023 Q1
2 quarters
TLIS icon
34
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$860K 0.05%
149,052
– –
2021 Q4
7 quarters
NBSE icon
35
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$119K 0.01%
136,350
– –
2019 Q3
16 quarters
NUVB icon
36
Nuvation Bio
NUVB
$1.67B
$46.9K ﹤0.01%
34,995
– –
2020 Q3
12 quarters
NUVB.WS icon
37
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$10K ﹤0.01%
100,000
– –
2021 Q1
10 quarters
KPLTW icon
38
DELISTED
Katapult Holdings Warrant
KPLTW
$2.67K ﹤0.01%
262,227
– –
2021 Q1
10 quarters
FSRXW
39
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$2.38K ﹤0.01%
78,750
– –
2023 Q1
2 quarters
CPRI icon
40
Capri Holdings
CPRI
$1.8B
– –
-1,646,136
Closed -$59.1M –
BKI
41
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-1,336,800
Closed -$79.8M –
WAVC.U
42
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
– –
-350,000
Closed -$3.64M –

Similar funds

Greenlight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Greenlight Capital held 42 positions worth $1.76B, down 17% from $2.13B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Greenlight Capital withdrew a net $265M in Q3 2023, closing 3 positions and reducing 7 holdings. Its most notable exit was Black Knight, Inc. Common Stock, an estimated $79.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 52% a quarter earlier, followed by Energy and Financials.

Against the trend, Greenlight Capital opened a new position in DHT Holdings worth $20.9M.

  • Greenlight Capital's largest Q3 2023 buy was DHT Holdings: 2,024,820 shares worth $20.9M.
  • Greenlight Capital added most to SPDR Gold Trust in Q3 2023, an estimated $36.4M increase.
  • Greenlight Capital's biggest Q3 2023 reduction was Green Brick Partners, cutting an estimated $213M.
  • Greenlight Capital fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $79.8M.
  • Greenlight Capital's ten largest holdings make up 80% of its $1.76B portfolio in Q3 2023.
  • Greenlight Capital opened 1 new position and closed 3 in Q3 2023.
  • Greenlight Capital's portfolio value fell 17% quarter-over-quarter to $1.76B.

Based on Greenlight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.